Wei Wei
Yale Cancer Center(US)Yale University(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Melanoma and MAPK Pathways, Acute Myeloid Leukemia Research, Immunotherapy and Immune Responses
Most-Cited Works
- → Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial(2020)530 cited
- → Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial(2018)276 cited
- → Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma(2019)212 cited
- → Methods for Analysis of Pre-Post Data in Clinical Research: A Comparison of Five Common Methods(2017)182 cited
- → Role of the Indirect Pathway of the Basal Ganglia in Perceptual Decision Making(2015)101 cited
- → A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1(2021)92 cited
- → Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study(2020)92 cited
- → Type 3 Inositol 1,4,5‐Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma(2019)72 cited
- → Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma(2019)70 cited
- → Loss of MLL PHD Finger 3 Is Necessary for MLL-ENL–Induced Hematopoietic Stem Cell Immortalization(2008)68 cited